BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L, Lanzi G, Ansari AA, Coppel RL, Zhang P, Li Y, Zhou Z, Lu Q, Gershwin ME. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 2012;55:153-60. [PMID: 21898485 DOI: 10.1002/hep.24630] [Cited by in Crossref: 91] [Cited by in F6Publishing: 83] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Gulamhusein AF, Hirschfield GM. Pathophysiology of primary biliary cholangitis. Best Practice & Research Clinical Gastroenterology 2018;34-35:17-25. [DOI: 10.1016/j.bpg.2018.05.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
2 Yan C, Koda S, Wu J, Zhang BB, Yu Q, Netea MG, Tang RX, Zheng KY. Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target. Hepatology 2020;72:1838-50. [PMID: 32463941 DOI: 10.1002/hep.31395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
3 Aslani S, Mahmoudi M, Karami J, Jamshidi AR, Malekshahi Z, Nicknam MH. Epigenetic alterations underlying autoimmune diseases. Autoimmunity 2015;49:69-83. [DOI: 10.3109/08916934.2015.1134511] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
4 Selmi C, Cavaciocchi F, Lleo A, Cheroni C, De Francesco R, Lombardi SA, De Santis M, Meda F, Raimondo MG, Crotti C. Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis. Front Immunol. 2014;5:128. [PMID: 24734033 DOI: 10.3389/fimmu.2014.00371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Aslani S, Sobhani S, Gharibdoost F, Jamshidi A, Mahmoudi M. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs. Hum Immunol 2018;79:178-87. [PMID: 29330110 DOI: 10.1016/j.humimm.2018.01.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
6 Islam N, Leung PS, Huntley AC, Eric Gershwin M. The autoimmune basis of alopecia areata: A comprehensive review. Autoimmunity Reviews 2015;14:81-9. [DOI: 10.1016/j.autrev.2014.10.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 11.7] [Reference Citation Analysis]
7 Lleo A, Marzorati S, Anaya JM, Gershwin ME. Primary biliary cholangitis: a comprehensive overview. Hepatol Int 2017;11:485-99. [PMID: 29164395 DOI: 10.1007/s12072-017-9830-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 13.4] [Reference Citation Analysis]
8 Rodrigues PM, Perugorria MJ, Santos-laso A, Bujanda L, Beuers U, Banales JM. Primary biliary cholangitis: A tale of epigenetically-induced secretory failure? Journal of Hepatology 2018;69:1371-83. [DOI: 10.1016/j.jhep.2018.08.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
9 Carbone M, Invernizzi P. Novel treatments targeting immune-related mechanisms in primary biliary cholangitis. Clin Liver Dis (Hoboken) 2016;8:127-31. [PMID: 31041080 DOI: 10.1002/cld.587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Liao J, Liang G, Xie S, Zhao H, Zuo X, Li F, Chen J, Zhao M, Chan TM, Lu Q. CD40L demethylation in CD4(+) T cells from women with rheumatoid arthritis. Clin Immunol 2012;145:13-8. [PMID: 22889643 DOI: 10.1016/j.clim.2012.07.006] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
11 Shi TY, Zhang FC. Role of autoimmunity in primary biliary cirrhosis. World J Gastroenterol 2012; 18(48): 7141-7148 [PMID: 23326118 DOI: 10.3748/wjg.v18.i48.7141] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang Q, Selmi C, Zhou X, Qiu D, Li Z, Miao Q, Chen X, Wang J, Krawitt EL, Gershwin ME, Han Y, Ma X. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. Journal of Autoimmunity 2013;41:140-5. [DOI: 10.1016/j.jaut.2012.10.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
13 Selmi C, Cavaciocchi F, Lleo A, Cheroni C, De Francesco R, Lombardi SA, De Santis M, Meda F, Raimondo MG, Crotti C. Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis. Front Immunol. 2014;5:128. [PMID: 24734033 DOI: 10.3389/fimmu.2014.00128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
14 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145-172. [PMID: 28427765 DOI: 10.1016/j.jhep.2017.03.022] [Cited by in Crossref: 409] [Cited by in F6Publishing: 326] [Article Influence: 81.8] [Reference Citation Analysis]
15 Cheung AC, LaRusso NF, Gores GJ, Lazaridis KN. Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Semin Liver Dis 2017;37:159-74. [PMID: 28564724 DOI: 10.1055/s-0037-1603324] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
16 Zhang P, Lu Q. Genetic and epigenetic influences on the loss of tolerance in autoimmunity. Cell Mol Immunol 2018;15:575-85. [PMID: 29503444 DOI: 10.1038/cmi.2017.137] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
17 Chang C. Unmet needs in the treatment of autoimmunity: from aspirin to stem cells. Autoimmun Rev 2014;13:331-46. [PMID: 24462645 DOI: 10.1016/j.autrev.2014.01.052] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
18 Webb GJ, Hirschfield GM. Follicles, germinal centers, and immune mechanisms in primary biliary cirrhosis. Hepatology 2015;61:424-7. [PMID: 25294750 DOI: 10.1002/hep.27552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
19 Chen R, Meng X, Zhao A, Wang C, Yang C, Li H, Cai J, Zhao Z, Kan H. DNA hypomethylation and its mediation in the effects of fine particulate air pollution on cardiovascular biomarkers: A randomized crossover trial. Environ Int 2016;94:614-9. [PMID: 27397927 DOI: 10.1016/j.envint.2016.06.026] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
20 Arenas F, Hervías I, Sáez E, Melero S, Prieto J, Parés A, Medina JF. Promoter hypermethylation of the AE2/SLC4A2 gene in PBC. JHEP Rep 2019;1:145-53. [PMID: 32039364 DOI: 10.1016/j.jhepr.2019.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
21 Mayo MJ. Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis? Hepatology 2022. [PMID: 35152430 DOI: 10.1002/hep.32405] [Reference Citation Analysis]
22 Wang C, Shi Y, Wang X, Ma H, Liu Q, Gao Y, Niu J. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis. Front Immunol 2022;13:940688. [DOI: 10.3389/fimmu.2022.940688] [Reference Citation Analysis]
23 Wang TJ, Wu LF, Chen J, Zhu W, Wang H, Liu XL, Teng YQ. X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene. Immunol Res 2019;67:454-9. [PMID: 31754970 DOI: 10.1007/s12026-019-09098-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Ma W, Chen D. Immunological abnormalities in patients with primary biliary cholangitis. Clinical Science 2019;133:741-60. [DOI: 10.1042/cs20181123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
25 Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J Autoimmun. 2015;57:1-13. [PMID: 25578468 DOI: 10.1016/j.jaut.2014.12.002] [Cited by in Crossref: 236] [Cited by in F6Publishing: 200] [Article Influence: 33.7] [Reference Citation Analysis]
26 Gerussi A, Paraboschi EM, Cappadona C, Caime C, Binatti E, Cristoferi L, Asselta R, Invernizzi P. The Role of Epigenetics in Primary Biliary Cholangitis. Int J Mol Sci 2022;23:4873. [PMID: 35563266 DOI: 10.3390/ijms23094873] [Reference Citation Analysis]
27 Tough DF, Tak PP, Tarakhovsky A, Prinjha RK. Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov 2016;15:835-53. [DOI: 10.1038/nrd.2016.185] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 14.3] [Reference Citation Analysis]
28 Xie Y, Ma H, Lian Z. Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity. Clinic Rev Allerg Immunol 2016;50:390-403. [DOI: 10.1007/s12016-015-8502-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
29 Zhao M, Liu Q, Liang G, Wang L, Luo S, Tang Q, Zhao H, Su Y, Yung S, Chan TM, Lu Q. E4BP4 overexpression: A protective mechanism in CD4+ T cells from SLE patients. Journal of Autoimmunity 2013;41:152-60. [DOI: 10.1016/j.jaut.2013.01.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
30 Drazilova S, Babinska I, Gazda J, Halanova M, Janicko M, Kucinsky B, Safcak D, Martinkova D, Tarbajova L, Cekanova A, Jarcuska P; Eastern Slovakia PBC Group. Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia. Int J Public Health 2020;65:683-91. [PMID: 32500239 DOI: 10.1007/s00038-020-01391-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Fiorucci S, Biagioli M, Zampella A, Distrutti E. Bile Acids Activated Receptors Regulate Innate Immunity. Front Immunol 2018;9:1853. [PMID: 30150987 DOI: 10.3389/fimmu.2018.01853] [Cited by in Crossref: 123] [Cited by in F6Publishing: 118] [Article Influence: 30.8] [Reference Citation Analysis]
32 Marzorati S, Lleo A, Carbone M, Gershwin ME, Invernizzi P. The epigenetics of PBC: The link between genetic susceptibility and environment. Clin Res Hepatol Gastroenterol 2016;40:650-9. [PMID: 27341761 DOI: 10.1016/j.clinre.2016.05.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
33 Lleo A, Zhang W, Zhao M, Tan Y, Bernuzzi F, Zhu B, Liu Q, Tan Q, Malinverno F, Valenti L, Jiang T, Tan L, Liao W, Coppel R, Invernizzi P, Lu Q, Adams DH, Gershwin ME; PBC Epigenetic Study Group. DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis. Clin Epigenetics. 2015;7:61. [PMID: 26150899 DOI: 10.1186/s13148-015-0098-9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 8.7] [Reference Citation Analysis]
34 Tanaka H, Yang GX, Iwakoshi N, Knechtle SJ, Kawata K, Tsuneyama K, Leung P, Coppel RL, Ansari AA, Joh T, Bowlus C, Gershwin ME. Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol. 2013;174:364-371. [PMID: 23981074 DOI: 10.1111/cei.12193] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
35 Wang C, Chen R, Shi M, Cai J, Shi J, Yang C, Li H, Lin Z, Meng X, Liu C, Niu Y, Xia Y, Zhao Z, Kan H, Weinberg CR. Possible Mediation by Methylation in Acute Inflammation Following Personal Exposure to Fine Particulate Air Pollution. Am J Epidemiol 2018;187:484-93. [PMID: 29020142 DOI: 10.1093/aje/kwx277] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
36 Ding D, Xuan G, Hu Y, Yu J, Liu Y, Guo G, Ma S, Yang F, Tian S, Ma G, Chen L, Zhou X, Shang Y, Han Y. Immunoglobulin M: A Neglected Serum Biomarker in Treatment-Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase. Hepatol Commun 2022. [PMID: 35182047 DOI: 10.1002/hep4.1907] [Reference Citation Analysis]
37 Shuai Z, Leung MW, He X, Zhang W, Yang G, Leung PS, Eric Gershwin M. Adaptive immunity in the liver. Cell Mol Immunol 2016;13:354-68. [PMID: 26996069 DOI: 10.1038/cmi.2016.4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
38 Ronca V, Mancuso C, Milani C, Carbone M, Oo YH, Invernizzi P. Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis. J Leukoc Biol 2020;108:659-71. [PMID: 32349179 DOI: 10.1002/JLB.5MR0320-200R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Webb GJ, Siminovitch KA, Hirschfield GM. The immunogenetics of primary biliary cirrhosis: A comprehensive review. J Autoimmun. 2015;64:42-52. [PMID: 26250073 DOI: 10.1016/j.jaut.2015.07.004] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 11.4] [Reference Citation Analysis]
40 Uibo R, Kisand K, Yang CY, Gershwin ME. Primary biliary cirrhosis: a multi-faced interactive disease involving genetics, environment and the immune response. APMIS. 2012;120:857-871. [PMID: 23009110 DOI: 10.1111/j.1600-0463.2012.02914.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
41 Gatselis NK, Dalekos GN. Molecular diagnostic testing for primary biliary cholangitis. Expert Review of Molecular Diagnostics 2016;16:1001-10. [DOI: 10.1080/14737159.2016.1217159] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
42 Chen RC, Naiyanetr P, Shu SA, Wang J, Yang GX, Kenny TP, Guggenheim KC, Butler JD, Bowlus C, Tao MH, Kurth MJ, Ansari AA, Kaplan M, Coppel RL, Lleo A, Gershwin ME, Leung PS. Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology 2013;57:1498-508. [PMID: 23184636 DOI: 10.1002/hep.26157] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
43 Roberto R, Laura C, Atsushi T, Pietro I. Geoepidemiology and (epi-)genetics in primary biliary cholangitis. Best Practice & Research Clinical Gastroenterology 2018;34-35:11-5. [DOI: 10.1016/j.bpg.2018.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
44 Chiaroni-clarke RC, Munro JE, Ellis JA. Sex bias in paediatric autoimmune disease – Not just about sex hormones? Journal of Autoimmunity 2016;69:12-23. [DOI: 10.1016/j.jaut.2016.02.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
45 Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369-395. [PMID: 26212387 DOI: 10.1111/joim.12395] [Cited by in Crossref: 236] [Cited by in F6Publishing: 209] [Article Influence: 33.7] [Reference Citation Analysis]
46 Trivedi PJ, Hirschfield GM. The Immunogenetics of Autoimmune Cholestasis. Clin Liver Dis. 2016;20:15-31. [PMID: 26593288 DOI: 10.1016/j.cld.2015.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
47 Velmurugan BK, Chang R, Marthandam Asokan S, Chang C, Day C, Lin Y, Lin Y, Kuo W, Huang C. A minireview of E4BP4/NFIL3 in heart failure. J Cell Physiol 2018;233:8458-66. [DOI: 10.1002/jcp.26790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Lu Q. The critical importance of epigenetics in autoimmunity. J Autoimmun 2013;41:1-5. [PMID: 23375849 DOI: 10.1016/j.jaut.2013.01.010] [Cited by in Crossref: 117] [Cited by in F6Publishing: 104] [Article Influence: 13.0] [Reference Citation Analysis]
49 Gao L, Wang L, Woo E, He X, Yang G, Bowlus C, Leung PSC, Gershwin ME. Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends. Clin Rev Allergy Immunol. 2019;. [PMID: 31713023 DOI: 10.1007/s12016-019-08772-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
50 Lleo A, Colapietro F. Changes in the Epidemiology of Primary Biliary Cholangitis. Clin Liver Dis 2018;22:429-41. [PMID: 30259845 DOI: 10.1016/j.cld.2018.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
51 Shi TY, Zhang FC. Role of autoimmunity in primary biliary cirrhosis. World J Gastroenterol. 2012;18:7141-7148. [PMID: 23326118 DOI: 10.3748/wjgv.18.i48.7141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Tsuchiya Y, Naito T, Tenno M, Maruyama M, Koseki H, Taniuchi I, Naoe Y. ThPOK represses CXXC5, which induces methylation of histone H3 lysine 9 in Cd40lg promoter by association with SUV39H1: implications in repression of CD40L expression in CD8+ cytotoxic T cells. J Leukoc Biol 2016;100:327-38. [PMID: 26896487 DOI: 10.1189/jlb.1A0915-396RR] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
53 Greer JM, McCombe PA. The role of epigenetic mechanisms and processes in autoimmune disorders. Biologics 2012;6:307-27. [PMID: 23055689 DOI: 10.2147/BTT.S24067] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
54 Li Y, Tang R, Ma X. Epigenetics of Primary Biliary Cholangitis. Adv Exp Med Biol 2020;1253:259-83. [PMID: 32445099 DOI: 10.1007/978-981-15-3449-2_10] [Reference Citation Analysis]
55 Cargill T, Culver EL. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Front Immunol 2021;12:661196. [PMID: 33936097 DOI: 10.3389/fimmu.2021.661196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun. 2016;66:25-39. [PMID: 26347073 DOI: 10.1016/j.jaut.2015.08.016] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 9.6] [Reference Citation Analysis]
57 de la Morena MT. Clinical Phenotypes of Hyper-IgM Syndromes. J Allergy Clin Immunol Pract 2016;4:1023-36. [PMID: 27836054 DOI: 10.1016/j.jaip.2016.09.013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
58 Chaudhry S, Emond J, Griesemer A. Immune Cell Trafficking to the Liver. Transplantation 2019;103:1323-37. [PMID: 30817405 DOI: 10.1097/TP.0000000000002690] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
59 Tanaka A, Leung PS, Gershwin ME. Evolution of our understanding of PBC. Best Practice & Research Clinical Gastroenterology 2018;34-35:3-9. [DOI: 10.1016/j.bpg.2018.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
60 Mousa HS, Lleo A, Invernizzi P, Bowlus CL, Gershwin ME. Advances in pharmacotherapy for primary biliary cirrhosis. Expert Opin Pharmacother. 2015;16:633-643. [PMID: 25543678 DOI: 10.1517/14656566.2015.998650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
61 Bianchi I, Lleo A, Gershwin ME, Invernizzi P. The X chromosome and immune associated genes. J Autoimmun. 2012;38:J187-J192. [PMID: 22178198 DOI: 10.1016/j.jaut.2011.11.012] [Cited by in Crossref: 161] [Cited by in F6Publishing: 156] [Article Influence: 14.6] [Reference Citation Analysis]
62 Ueno K, Aiba Y, Hitomi Y, Shimoda S, Nakamura H, Gervais O, Kawai Y, Kawashima M, Nishida N, Kohn SS, Kojima K, Katsushima S, Naganuma A, Sugi K, Komatsu T, Mannami T, Matsushita K, Yoshizawa K, Makita F, Nikami T, Nishimura H, Kouno H, Kouno H, Ohta H, Komura T, Tsuruta S, Yamauchi K, Kobata T, Kitasato A, Kuroki T, Abiru S, Nagaoka S, Komori A, Yatsuhashi H, Migita K, Ohira H, Tanaka A, Takikawa H, Nagasaki M, Tokunaga K, Nakamura M; PBC‐GWAS Consortium in Japan. Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis. Hepatol Commun 2020;4:724-38. [PMID: 32363322 DOI: 10.1002/hep4.1497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Huang YQ. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World J Hepatol 2016; 8(33): 1419-1441 [PMID: 27957241 DOI: 10.4254/wjh.v8.i33.1419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
64 Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL, Ansari AA, Yang GX, Wang J, Kenny TP, He XS, Mackay IR, Gershwin ME. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 2014;60:1708-16. [PMID: 25043065 DOI: 10.1002/hep.27313] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
65 Arvaniti P, Zachou K, Lyberopoulou A, Gatselis NK, Brooks WH, Dalekos GN, Renaudineau Y. Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis. Epigenomes 2019;3:15. [PMID: 34968227 DOI: 10.3390/epigenomes3030015] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
66 Trivedi HD, Lizaola B, Tapper EB, Bonder A. Primary biliary cholangitis: new treatments for an old disease. Frontline Gastroenterol 2017;8:29-36. [PMID: 28839882 DOI: 10.1136/flgastro-2016-100741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
67 Czaja AJ. Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Front Immunol 2022;13:921765. [DOI: 10.3389/fimmu.2022.921765] [Reference Citation Analysis]
68 Mousa HS, Carbone M, Malinverno F, Ronca V, Gershwin ME, Invernizzi P. Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach. Autoimmunity Reviews 2016;15:870-6. [DOI: 10.1016/j.autrev.2016.07.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
69 Wu H, Chen Y, Zhu H, Zhao M, Lu Q. The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases. Front Immunol 2019;10:2305. [PMID: 31611879 DOI: 10.3389/fimmu.2019.02305] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
70 Silveira MG, Lindor KD. Investigational drugs in phase II clinical trials for primary biliary cholangitis. Expert Opinion on Investigational Drugs 2017;26:1115-21. [DOI: 10.1080/13543784.2017.1371135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Selmi C, Brunetta E, Raimondo MG, Meroni PL. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev. 2012;11:A531-A537. [PMID: 22155196 DOI: 10.1016/j.autrev.2011.11.024] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
72 McDaniel K, Meng F, Wu N, Sato K, Venter J, Bernuzzi F, Invernizzi P, Zhou T, Kyritsi K, Wan Y, Huang Q, Onori P, Francis H, Gaudio E, Glaser S, Alpini G. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡. Hepatology 2017;65:544-59. [PMID: 27639079 DOI: 10.1002/hep.28831] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
73 Gao L, Zhang Y, Gao X, Xu L, Duan X. Methylation of the HCBP6 promoter is associated with primary biliary cholangitis pathogenesis. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.03.080] [Reference Citation Analysis]
74 Wu H, Liao J, Li Q, Yang M, Zhao M, Lu Q. Epigenetics as biomarkers in autoimmune diseases. Clin Immunol 2018;196:34-9. [PMID: 29574040 DOI: 10.1016/j.clim.2018.03.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
75 Leung KK, Deeb M, Hirschfield GM. Review article: pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol Ther. [DOI: 10.1111/apt.16023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
76 Gerussi A, Cristoferi L, Carbone M, Asselta R, Invernizzi P. The immunobiology of female predominance in primary biliary cholangitis. Journal of Autoimmunity 2018;95:124-32. [DOI: 10.1016/j.jaut.2018.10.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
77 Yamagiwa S, Kamimura H, Takamura M, Aoyagi Y. Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance. World J Gastroenterol 2014; 20(10): 2606-2612 [PMID: 24627596 DOI: 10.3748/wjg.v20.i10.2606] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
78 Barbouche MR, Chen Q, Carbone M, Ben-Mustapha I, Shums Z, Trifa M, Malinverno F, Bernuzzi F, Zhang H, Agrebi N, Norman GL, Chang C, Gershwin ME, Invernizzi P. Comprehensive review of autoantibodies in patients with hyper-IgM syndrome. Cell Mol Immunol 2018;15:610-7. [PMID: 29400703 DOI: 10.1038/cmi.2017.140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Li H, Xuan M, Yang R. DNA methylation and primary immune thrombocytopenia. Semin Hematol 2013;50 Suppl 1:S116-26. [PMID: 23664508 DOI: 10.1053/j.seminhematol.2013.03.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
80 Yasunami M, Nakamura H, Tokunaga K, Kawashima M, Nishida N, Hitomi Y, Nakamura M. Principal contribution of HLA-DQ alleles, DQB1*06:04 and DQB1*03:01, to disease resistance against primary biliary cholangitis in a Japanese population. Sci Rep 2017;7:11093. [PMID: 28894202 DOI: 10.1038/s41598-017-11148-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
81 Long H, Yin H, Wang L, Gershwin ME, Lu Q. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. J Autoimmun 2016;74:118-38. [PMID: 27396525 DOI: 10.1016/j.jaut.2016.06.020] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 16.8] [Reference Citation Analysis]
82 Tanaka A, Leung PS, Gershwin ME. The Genetics and Epigenetics of Primary Biliary Cholangitis. Clinics in Liver Disease 2018;22:443-55. [DOI: 10.1016/j.cld.2018.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
83 Sun Y, Haapanen K, Li B, Zhang W, Van de Water J, Gershwin ME. Women and primary biliary cirrhosis. Clin Rev Allergy Immunol 2015;48:285-300. [PMID: 25241227 DOI: 10.1007/s12016-014-8449-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
84 Liu Q, Li Y, Ma X, Tang R. Epigenetics of autoimmune liver diseases: current progress and future directions. Journal of Bio-X Research 2019;2:46-55. [DOI: 10.1097/jbr.0000000000000030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 You Z, Wang Q, Bian Z, Liu Y, Han X, Peng Y, Shen L, Chen X, Qiu D, Selmi C, Gershwin ME, Ma X. The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun 2012;39:216-21. [PMID: 22727562 DOI: 10.1016/j.jaut.2012.05.022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
86 Floreani A, Franceschet I, Cazzagon N, Spinazzè A, Buja A, Furlan P, Baldo V, Gershwin ME. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48:192-197. [PMID: 24809534 DOI: 10.1007/s12016-014-8427-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 67] [Article Influence: 14.7] [Reference Citation Analysis]